US Stock MarketDetailed Quotes

Centessa Pharmaceuticals (CNTA)

Watchlist
  • 25.270
  • +0.620+2.52%
Close Jan 23 16:00 ET
  • 25.500
  • +0.230+0.91%
Post 20:01 ET
3.69BMarket Cap-13.37P/E (TTM)

Centessa Pharmaceuticals (CNTA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
15M
0
0
0
0
0
6.85M
6.85M
Operating revenue
--0
--0
--15M
--0
--0
--0
--0
--0
--6.85M
--6.85M
Cost of revenue
Gross profit
Operating expense
15.91%53.79M
24.27%54.65M
26.84%45.78M
12.87%201.06M
77.44%74.58M
15.41%46.41M
-6.46%43.98M
-26.16%36.09M
-15.29%178.14M
1.03%42.03M
Selling and administrative expenses
-2.20%12.23M
6.69%11.91M
-8.22%12.33M
-5.43%50.81M
11.30%13.71M
4.02%12.5M
-16.34%11.17M
-16.28%13.44M
-2.66%53.73M
-10.55%12.32M
-General and administrative expense
-2.20%12.23M
6.69%11.91M
-8.22%12.33M
-5.43%50.81M
11.30%13.71M
4.02%12.5M
-16.34%11.17M
-16.28%13.44M
-2.66%53.73M
-10.55%12.32M
Research and development costs
22.59%41.56M
30.25%42.74M
47.64%33.44M
20.77%150.24M
104.85%60.87M
20.27%33.9M
-2.55%32.82M
-30.99%22.65M
-19.78%124.41M
6.76%29.72M
Operating profit
-15.91%-53.79M
-24.27%-54.65M
14.72%-30.78M
-17.38%-201.06M
-112.01%-74.58M
-15.41%-46.41M
6.46%-43.98M
26.16%-36.09M
18.55%-171.28M
15.44%-35.18M
Net non-operating interest income expense
11.75%875K
109.23%1.5M
7,985.48%5.01M
588.77%3.93M
551.79%2.37M
90.05%783K
282.86%715K
-66.67%62K
108.10%570K
116.77%363K
Non-operating interest income
12.72%3.77M
35.19%4.38M
204.52%7.89M
33.79%14.02M
65.19%4.85M
13.11%3.34M
57.36%3.24M
2.37%2.59M
4,193.44%10.48M
7,420.51%2.93M
Non-operating interest expense
13.02%2.89M
14.22%2.88M
13.76%2.88M
1.86%10.09M
-3.54%2.48M
0.63%2.56M
3.06%2.53M
7.85%2.53M
36.13%9.91M
16.66%2.57M
Other net income (expense)
-149.40%-1.81M
2,232.47%3.59M
166.75%1.03M
-559.25%-35.78M
-4,235.42%-38.07M
318.49%3.66M
110.09%154K
-14.19%-1.54M
-1,599.45%-5.43M
-1,154.29%-878K
Special income (charges)
----
----
----
---34.1M
----
----
----
----
--0
----
-Less:Other special charges
----
----
----
--34.1M
----
----
----
----
----
----
Other non- operating income (expenses)
-149.40%-1.81M
2,232.47%3.59M
166.75%1.03M
68.92%-1.69M
-351.94%-3.97M
318.49%3.66M
110.09%154K
-14.19%-1.54M
-331.77%-5.43M
-1,154.29%-878K
Income before tax
-30.43%-54.73M
-14.97%-49.57M
34.15%-24.74M
-32.23%-232.91M
-208.97%-110.28M
-1.17%-41.96M
11.91%-43.11M
24.93%-37.57M
18.81%-176.14M
18.58%-35.69M
Income tax
-72.70%166K
10.35%778K
190.44%1.4M
111.35%2.84M
-8.22%1.05M
121.51%608K
102.93%705K
-28.95%481K
-3,254.22%-25.06M
272.29%1.14M
Net income
-28.96%-54.89M
-14.90%-50.34M
31.31%-26.14M
-56.04%-235.76M
-202.22%-111.33M
-10.14%-42.57M
-76.07%-43.82M
24.98%-38.05M
30.12%-151.09M
14.68%-36.84M
Net income continuous Operations
-28.96%-54.89M
-14.90%-50.34M
31.31%-26.14M
-56.04%-235.76M
-202.22%-111.33M
-10.14%-42.57M
-76.07%-43.82M
24.98%-38.05M
30.12%-151.09M
14.68%-36.84M
Minority interest income
Net income attributable to the parent company
-28.96%-54.89M
-14.90%-50.34M
31.31%-26.14M
-56.04%-235.76M
-202.22%-111.33M
-10.14%-42.57M
-76.07%-43.82M
24.98%-38.05M
30.12%-151.09M
14.68%-36.84M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-28.96%-54.89M
-14.90%-50.34M
31.31%-26.14M
-56.04%-235.76M
-202.22%-111.33M
-10.14%-42.57M
-76.07%-43.82M
24.98%-38.05M
30.12%-151.09M
14.68%-36.84M
Basic earnings per share
-10.81%-0.41
5.00%-0.38
47.37%-0.2
-31.21%-2.06
-127.03%-0.84
7.50%-0.37
-53.85%-0.4
28.30%-0.38
32.03%-1.57
17.78%-0.37
Diluted earnings per share
-10.81%-0.41
5.00%-0.38
47.37%-0.2
-31.21%-2.06
-127.03%-0.84
7.50%-0.37
-53.85%-0.4
28.30%-0.38
32.03%-1.57
17.78%-0.37
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0015M000006.85M6.85M
Operating revenue --0--0--15M--0--0--0--0--0--6.85M--6.85M
Cost of revenue
Gross profit
Operating expense 15.91%53.79M24.27%54.65M26.84%45.78M12.87%201.06M77.44%74.58M15.41%46.41M-6.46%43.98M-26.16%36.09M-15.29%178.14M1.03%42.03M
Selling and administrative expenses -2.20%12.23M6.69%11.91M-8.22%12.33M-5.43%50.81M11.30%13.71M4.02%12.5M-16.34%11.17M-16.28%13.44M-2.66%53.73M-10.55%12.32M
-General and administrative expense -2.20%12.23M6.69%11.91M-8.22%12.33M-5.43%50.81M11.30%13.71M4.02%12.5M-16.34%11.17M-16.28%13.44M-2.66%53.73M-10.55%12.32M
Research and development costs 22.59%41.56M30.25%42.74M47.64%33.44M20.77%150.24M104.85%60.87M20.27%33.9M-2.55%32.82M-30.99%22.65M-19.78%124.41M6.76%29.72M
Operating profit -15.91%-53.79M-24.27%-54.65M14.72%-30.78M-17.38%-201.06M-112.01%-74.58M-15.41%-46.41M6.46%-43.98M26.16%-36.09M18.55%-171.28M15.44%-35.18M
Net non-operating interest income expense 11.75%875K109.23%1.5M7,985.48%5.01M588.77%3.93M551.79%2.37M90.05%783K282.86%715K-66.67%62K108.10%570K116.77%363K
Non-operating interest income 12.72%3.77M35.19%4.38M204.52%7.89M33.79%14.02M65.19%4.85M13.11%3.34M57.36%3.24M2.37%2.59M4,193.44%10.48M7,420.51%2.93M
Non-operating interest expense 13.02%2.89M14.22%2.88M13.76%2.88M1.86%10.09M-3.54%2.48M0.63%2.56M3.06%2.53M7.85%2.53M36.13%9.91M16.66%2.57M
Other net income (expense) -149.40%-1.81M2,232.47%3.59M166.75%1.03M-559.25%-35.78M-4,235.42%-38.07M318.49%3.66M110.09%154K-14.19%-1.54M-1,599.45%-5.43M-1,154.29%-878K
Special income (charges) ---------------34.1M------------------0----
-Less:Other special charges --------------34.1M------------------------
Other non- operating income (expenses) -149.40%-1.81M2,232.47%3.59M166.75%1.03M68.92%-1.69M-351.94%-3.97M318.49%3.66M110.09%154K-14.19%-1.54M-331.77%-5.43M-1,154.29%-878K
Income before tax -30.43%-54.73M-14.97%-49.57M34.15%-24.74M-32.23%-232.91M-208.97%-110.28M-1.17%-41.96M11.91%-43.11M24.93%-37.57M18.81%-176.14M18.58%-35.69M
Income tax -72.70%166K10.35%778K190.44%1.4M111.35%2.84M-8.22%1.05M121.51%608K102.93%705K-28.95%481K-3,254.22%-25.06M272.29%1.14M
Net income -28.96%-54.89M-14.90%-50.34M31.31%-26.14M-56.04%-235.76M-202.22%-111.33M-10.14%-42.57M-76.07%-43.82M24.98%-38.05M30.12%-151.09M14.68%-36.84M
Net income continuous Operations -28.96%-54.89M-14.90%-50.34M31.31%-26.14M-56.04%-235.76M-202.22%-111.33M-10.14%-42.57M-76.07%-43.82M24.98%-38.05M30.12%-151.09M14.68%-36.84M
Minority interest income
Net income attributable to the parent company -28.96%-54.89M-14.90%-50.34M31.31%-26.14M-56.04%-235.76M-202.22%-111.33M-10.14%-42.57M-76.07%-43.82M24.98%-38.05M30.12%-151.09M14.68%-36.84M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -28.96%-54.89M-14.90%-50.34M31.31%-26.14M-56.04%-235.76M-202.22%-111.33M-10.14%-42.57M-76.07%-43.82M24.98%-38.05M30.12%-151.09M14.68%-36.84M
Basic earnings per share -10.81%-0.415.00%-0.3847.37%-0.2-31.21%-2.06-127.03%-0.847.50%-0.37-53.85%-0.428.30%-0.3832.03%-1.5717.78%-0.37
Diluted earnings per share -10.81%-0.415.00%-0.3847.37%-0.2-31.21%-2.06-127.03%-0.847.50%-0.37-53.85%-0.428.30%-0.3832.03%-1.5717.78%-0.37
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More